How many mL is 200 mg of testosterone? It depends on the concentration on your vial: from a 200 mg/mL vial, 200 mg is 1.0 mL; from a 100 mg/mL vial, the same 200 mg is 2.0 mL. FDA-approved testosterone cypionate (Depo-Testosterone) is supplied in both strengths, so the vial label, not a generic chart, decides the volume you draw [1].
This article is educational; follow your provider’s prescription and injection training. Testosterone cypionate is an FDA-approved prescription medication; any use outside the approved labeling is off-label and should be discussed with a licensed clinician.
Key takeaways
- mL to inject = mg prescribed ÷ mg/mL on the vial.
- At 200 mg/mL: 200 mg = 1.0 mL. At 100 mg/mL: 200 mg = 2.0 mL [1].
- Check the concentration on every new vial; the two approved strengths differ two-fold.
The one-line rule: how many mL is 200 mg of testosterone?
Prescriptions are written in milligrams (mg), syringes are marked in milliliters (mL), and the vial label gives the concentration (mg/mL) that connects them, so how many mL is 200 mg of testosterone cypionate depends on that label: at 200 mg/mL, 200 mg = 1.0 mL and 100 mg = 0.5 mL; at 100 mg/mL, 200 mg = 2.0 mL and 100 mg = 1.0 mL [1].
How mg relates to mL: the formula
mL = (mg prescribed) ÷ (mg per mL on your vial).
Different vial strengths change the volume, not the dose. The same 1.0 mL contains 100 mg from one approved vial and 200 mg from the other, so a reader who learned “200 mg = 1 mL” and then receives the 100 mg/mL vial draws half the prescribed dose [1]. Searches such as “200mg is how many ml”, “how much is 200 mg in ml”, “how many ml in 200mg” or “200mg/ml” all lead back to one step: read the concentration on your vial. A testosterone mL to mg calculator can do the division, but it cannot read your label.
Label-based conversion table: 100 mg/mL and 200 mg/mL
Volumes for common prescribed amounts at the two FDA-approved testosterone cypionate concentrations; the dose is always set by the prescriber.
| Prescribed dose | Volume at 100 mg/mL | Volume at 200 mg/mL | Status against the Depo-Testosterone label |
|---|---|---|---|
| 50 mg | 0.5 mL | 0.25 mL | Within the labeled 50–400 mg per-injection range (every two to four weeks) [1] |
| 100 mg | 1.0 mL | 0.5 mL | Within the labeled range [1] |
| 150 mg | 1.5 mL | 0.75 mL | Within the labeled range [1] |
| 200 mg | 2.0 mL | 1.0 mL | Within the labeled range [1] |
| 300 mg | 3.0 mL | 1.5 mL | Within the per-injection range on the label’s two-to-four-week schedule; see 300 mg testosterone per week[1] |
The label range describes an injection every two to four weeks, adjusted to response and adverse reactions; weekly or split schedules are the prescriber’s decision, not something to derive from this table [1]. For the dose question itself, start with 200 mg of testosterone a week.
Why 200 mg/mL is the common vial and when 100 mg/mL is dispensed
Both strengths are FDA-approved presentations of the same drug: the Depo-Testosterone label lists testosterone cypionate 200 mg/mL in 1 mL and 10 mL vials and testosterone cypionate 100 mg/mL in 10 mL vials. Which you receive depends on the prescription and pharmacy stock [1].
The 200 mg/mL strength is the one most readers search for (“testosterone cypionate 200 mg/ml”, “depo testosterone 200 mg ml”) because it delivers a dose in half the volume; neither is “stronger”, because the testosterone cypionate concentration (mg/mL) only changes how much liquid carries the milligrams. The labeled route is deep intramuscular injection into the gluteal muscle [1]. Other esters and strengths advertised online (for example 250 mg/mL) are not presentations in the Depo-Testosterone label, so never assume a strength from the drug name [1].
Understanding syringe markings
Syringes are graduated in mL, but the value of each line depends on the syringe size, so confirm what each mark represents with the pharmacist or clinician who trained you. At 200 mg/mL the 1.0 mL mark holds 200 mg and the 0.5 mL mark 100 mg; at 100 mg/mL the same marks hold 100 mg and 50 mg [1].
Some syringes print “cc” instead of “mL” (the same volume). ISMP lists “cc” as an error-prone abbreviation (mistaken for “u”, units) and recommends “mL”, which this article uses throughout [2].
Whether is 1 cc of testosterone a week enough or is 0.5 mL of testosterone a week enough are dose questions, not volume questions. Use only as prescribed; after a drawing error or a missed testosterone injection, contact the prescribing clinician or pharmacist.
Compounded testosterone: always read your own label
Compounded testosterone does not follow the two FDA-approved strengths, so a “testosterone mg to ml” chart written for the approved products can be wrong for a compounded vial. If your provider orders a compounded medication through a licensed 503A pharmacy, always verify the exact concentration printed on your specific prescription label.
Monitoring: the clinical backbone of safe therapy
The Endocrine Society’s 2018 clinical practice guideline states that testosterone therapy should begin only when symptoms are accompanied by consistently low early-morning testosterone on repeat testing, followed by a standardized monitoring plan [3]. Monitoring includes:
- Serum testosterone levels [3].
- Hemoglobin and hematocrit, checked periodically to detect polycythemia (erythrocytosis) [1].
- Blood pressure, because testosterone can increase blood pressure, which can increase cardiovascular risk over time [1].
- Prostate assessment (PSA and, when indicated, a prostate exam) before treatment and during the first year, for men in the appropriate age and risk group, decided with the clinician [3].
- Clinical review of symptoms, mood, energy and function [3].
Who should not use testosterone
Per the Depo-Testosterone label, testosterone cypionate is contraindicated in men with breast carcinoma or known or suspected prostate carcinoma, in women who are pregnant, and in serious cardiac, hepatic or renal disease; the warnings also advise against use in uncontrolled hypertension [1]. The Endocrine Society guideline recommends against starting therapy in men planning to father a child soon, because testosterone suppresses sperm production, and in men with elevated hematocrit, untreated severe sleep apnea, uncontrolled heart failure, or a heart attack or stroke within the previous 6 months [3].
Recent FDA labeling changes (2025 update)
On February 28, 2025, the U.S. Food and Drug Administration announced class-wide labeling changes for prescription testosterone: TRAVERSE results added, Boxed Warning language on cardiovascular risk removed, a blood pressure warning added where missing [4].
- TRAVERSE results added. In 5,246 men aged 45–80 years with low testosterone and existing or high cardiovascular risk, testosterone gel was noninferior to placebo for major adverse cardiovascular events (7.0% vs 7.3%; hazard ratio 0.96, 95% CI 0.78–1.17). The trial tested noninferiority, not benefit; atrial fibrillation, acute kidney injury and pulmonary embolism were more frequent with testosterone [5,6].
- Blood pressure warning strengthened. Ambulatory monitoring studies confirmed a blood pressure increase with all testosterone products [4].
- Age-related low T limitation remains. Testosterone is approved solely for men who lack or have low testosterone in conjunction with an associated medical condition [4].
Always review the current FDA-approved label of your product.
Telemedicine and controlled-substance rules
Testosterone is a Schedule III controlled substance under the Controlled Substances Act, so telehealth prescribing follows DEA rules as well as state law [7].
- As of November 2026, DEA and HHS have extended the federal telemedicine flexibilities for prescribing controlled medications through December 31, 2026 (Fourth Temporary Extension, 90 FR 61301), still subject to applicable federal and state law [8,9].
- DEA’s permanent Special Registration for Telemedicine rule, proposed January 17, 2025, had not been published as a final rule as of November 2026 [10,11].
Confirm that your provider operates within current DEA and state rules.
Closing thoughts
Testosterone cypionate is an FDA-approved option for men with low testosterone and an associated medical condition, not a remedy for age-related decline [4]. At home, read the concentration on every vial, draw the volume that matches the prescribed milligrams, and keep monitoring visits.
Learn more about getting checked for low testosterone or schedule a consultation with an independent licensed healthcare provider. Prescriptions are subject to clinical discretion, state law requirements, and confirmatory lab testing.
Important Notice: Testosterone is a Schedule III controlled substance. An online consultation does not guarantee a prescription; treatment is determined solely by an independent physician after required lab tests and medical evaluation. Telehealth availability varies by state law. If you experience sudden chest pain, shortness of breath, severe leg swelling, or other urgent symptoms, call 911 or visit an emergency room immediately. This article is for informational purposes only and does not constitute medical advice. Medical services are provided by independent licensed clinicians, not by Advanced TRT Clinic.